Acute Effect of Positive Expiratory Pressure Versus Breath Stacking Technique After Cardiac Surgery
1 other identifier
interventional
24
1 country
1
Brief Summary
This study evaluates the efficacy and safety of a single session of positive expiratory pressure and of breath stacking technique in patients after cardiac surgery. The same patients will receive the two interventions, with an interval of 24 hours, and the acute effect of each will be verifed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2019
CompletedFirst Posted
Study publicly available on registry
July 9, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2020
CompletedApril 9, 2020
April 1, 2020
5 months
July 2, 2019
April 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Tidal volume
It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period. This measurement will be obtained through the the division of the minute volume by the respiratory rate.
12 to 24 hours after removal of drains and 24 hours after primary intervention
Forced vital capacity (FVC)
It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period, as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability \<5%) and considered the best curve for the study.
12 to 24 hours after removal of drains and 24 hours after primary intervention
Secondary Outcomes (13)
Forced expiratory volume in the first second (FEV1)
12 to 24 hours after removal of drains and 24 hours after primary intervention
Peak expiratory flow (PEF)
12 to 24 hours after removal of drains and 24 hours after primary intervention
Forced expiratory flow between 25 and 75% of the curve of FVC (FEF25-75)
12 to 24 hours after removal of drains and 24 hours after primary intervention
Minute volume
12 to 24 hours after removal of drains and 24 hours after primary intervention
Respiratory rate
12 to 24 hours after removal of drains and 24 hours after primary intervention
- +8 more secondary outcomes
Study Arms (2)
Breath Stacking
ACTIVE COMPARATORInstrument composed of a one-way valve coupled to a face mask to promote the accumulation of successive inspiratory volumes.
Expiratory Positive Airway Pressure
ACTIVE COMPARATORTherapeutic technique consisting of a face mask, a one-way valve and an expiratory resistor, responsible for resistance to expiratory flow, which will determine the level of pressure in the airway.
Interventions
The patients will perform the maneuver through successive inspiratory efforts for 20 s. Subsequently, the expiratory branch will be unobstructed to allow expiration. This maneuver will be repeated 5 times in each series, with intervals of 30 seconds between them. The technique will be performed with the trunk inclined 30º in relation to the horizontal plane, in 3 series, with interval of 2 min completing 15 min of therapy.
Patients will perform exhalation of air through a facial mask containing an extrinsic positive expiratory pressure valve with a defined load of 10 cmH2O for 5 min. During the application of the technique the patients will have a trunk inclined 30º and will be stimulated to breathe normally, without effort or deep and fast breaths.
Eligibility Criteria
You may qualify if:
- Patients with indication for coronary artery bypass grafting and valve replacement, with surgical procedure for median sternotomy.
You may not qualify if:
- incapacity to understand the Informed Consent Form.
- cognitive dysfunction that prevents the performance of evaluations or interventions,
- intolerance to the use of EPAP or BS mask
- with chronic obstructive pulmonary disease (COPD)
- cerebrovascular disease
- chronic-degenerative musculoskeletal disease
- chronic infectious disease
- in treatment with steroids, hormones or cancer chemotherapy
- hemodynamic complications (arrhythmia, myocardial infarction during the operation, with blood loss ≥ 20% of the total blood volume, defined by Mannuci, et al., 2007)
- mean arterial pressure \<70 mmHg and reduced cardiac output, requiring the use of intra aortic balloon or vasoactive drugs
- tracheal intubation for more than 12 hours after admission to the ICU or reintubated
- individuals unable to maintain airway permeability.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Santa Maria
Santa Maria, Rio Grande do Sul, 97105-900, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 2, 2019
First Posted
July 9, 2019
Study Start
August 1, 2019
Primary Completion
December 30, 2019
Study Completion
February 4, 2020
Last Updated
April 9, 2020
Record last verified: 2020-04